We are live on ! Find out more
ST

SAL Trading Portfolio holdings

AUM $57M
1-Year Est. Return 33.89%
This Fund
S&P 500
This Quarter Est. Return
-15.59%
1 Year Est. Return
+33.89%
3 Year Est. Return
+18.85%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$236M
AUM Growth
-$194M
Cap. Flow
-$144M
Cap. Flow %
-61.01%
Top 10 Hldgs %
74.63%
Holding
65
New
15
Increased
8
Reduced
17
Closed
24

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$14.8M
2
SAP icon
SAP
SAP
+$10.4M
3
LIN icon
Linde
LIN
+$8M
4
SHEL icon
Shell
SHEL
+$5.44M
5
AZN icon
AstraZeneca
AZN
+$3.59M

Top Sells

Rank Stock Value
1
NOK icon
Nokia
NOK
+$38.8M
2
NVS icon
Novartis
NVS
+$13.7M
3
BP icon
BP
BP
+$9.49M
4
NVO
Novo Nordisk
NVO
+$5.98M
5
RYAAY icon
Ryanair
RYAAY
+$4.5M

Sector Composition

Rank Sector Weight
1 Technology 32.45%
2 Healthcare 3.13%
3 Materials 3.11%
4 Energy 2.42%
5 Consumer Discretionary 1.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MT icon
26
CALL
ArcelorMittal
MT
$49.5B
$832K 0.35%
36,800
+23,600
+179% +$692K
STM icon
27
PUT
STMicroelectronics
STM
$43.1B
$777K 0.33%
+24,700
New +$921K
NVO
28
CALL
Novo Nordisk
NVO
$228B
$669K 0.28%
+12,000
New +$666K
HSBC icon
29
HSBC
HSBC
$352B
$657K 0.28%
+20,100
New +$652K
RYAAY icon
30
Ryanair
RYAAY
$30B
$513K 0.22%
19,068
-134,377
-88% -$4.5M
FEZ icon
31
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.29B
$484K 0.2%
+13,900
New +$530K
SNY icon
32
Sanofi
SNY
$107B
$420K 0.18%
+8,400
New +$446K
ERIC icon
33
Ericsson
ERIC
$32.1B
$395K 0.17%
+53,400
New +$436K
TTE icon
34
TotalEnergies
TTE
$193B
$390K 0.17%
+7,400
New +$395K
SHEL icon
35
CALL
Shell
SHEL
$244B
$319K 0.13%
6,100
-381,000
-98% -$21.4M
AZN icon
36
PUT
AstraZeneca
AZN
$269B
$308K 0.13%
2,300
-14,900
-87% -$1.96M
BP icon
37
BP
BP
$112B
$278K 0.12%
9,800
-309,622
-97% -$9.49M
FRO icon
38
CALL
Frontline
FRO
$8.71B
$266K 0.11%
30,000
– –
SAN icon
39
PUT
Banco Santander
SAN
$191B
$239K 0.1%
85,200
-5,700
-6% -$17.4K
CS
40
CALL
DELISTED
Credit Suisse Group
CS
$221K 0.09%
38,900
+100
+0.3% +$679
CS
41
PUT
DELISTED
Credit Suisse Group
CS
$128K 0.05%
22,500
-24,000
-52% -$163K
AZN icon
42
CALL
AstraZeneca
AZN
$269B
– –
-20,000
Closed -$2.69M
BCS icon
43
CALL
Barclays
BCS
$87.8B
– –
-77,400
Closed -$611K
BCS icon
44
PUT
Barclays
BCS
$87.8B
– –
-572,100
Closed -$4.52M
BHP icon
45
PUT
BHP
BHP
$211B
– –
-19,730
Closed -$1.36M
BTI icon
46
PUT
British American Tobacco
BTI
$136B
– –
-79,000
Closed -$3.33M
DB icon
47
CALL
Deutsche Bank
DB
$67.9B
– –
-63,400
Closed -$802K
DB icon
48
PUT
Deutsche Bank
DB
$67.9B
– –
-12,400
Closed -$157K
E icon
49
PUT
ENI
E
$78.1B
– –
-36,700
Closed -$1.07M
ERIC icon
50
CALL
Ericsson
ERIC
$32.1B
– –
-75,000
Closed -$686K
1
2
3

Similar funds

ARC
Arias Resource Capital George Town, Grand Cayman, Cayman Islands $58.6M AUM 26.15% 1-Year Est. Return
AGFIA
Accel Growth Fund IV Associates Palo Alto, California $58.7M AUM 25.19% 1-Year Est. Return
SVG
Sun Valley Gold Sun Valley, Idaho $63.2M AUM 182.76% 1-Year Est. Return
TM
Titan Managers Scottsdale, Arizona $63.6M AUM 0.03% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return

SAL Trading's Q2 2022 Portfolio in Review

As of Q2 2022, SAL Trading held 65 positions worth $236M, down 45% from $430M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

SAL Trading withdrew a net $144M in Q2 2022, closing 24 positions and reducing 17 holdings. Its most notable exit was Novartis, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 25% a quarter earlier, followed by Healthcare and Materials.

Against the trend, SAL Trading opened a new position in ASML worth $12.7M.

  • SAL Trading's largest Q2 2022 buy was ASML: 26,600 shares worth $12.7M.
  • SAL Trading added most to AstraZeneca in Q2 2022, an estimated $3.59M increase.
  • SAL Trading's biggest Q2 2022 reduction was Nokia, cutting an estimated $38.8M.
  • SAL Trading fully exited Novartis in Q2 2022, selling an estimated $13.7M.
  • SAL Trading's ten largest holdings make up 75% of its $236M portfolio in Q2 2022.
  • SAL Trading opened 15 new positions and closed 24 in Q2 2022.
  • SAL Trading's portfolio value fell 45% quarter-over-quarter to $236M.

Based on SAL Trading's 13F filing for Q2 2022, filed 15 Aug 2022.